These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 10228090

  • 1. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
    Bustos DG, Canfield CJ, Canete-Miguel E, Hutchinson DB.
    J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
    Llanos-Cuentas A, Campos P, Clendenes M, Canfield CJ, Hutchinson DB.
    Braz J Infect Dis; 2001 Apr; 5(2):67-72. PubMed ID: 11493411
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN.
    Clin Infect Dis; 2004 Oct 15; 39(8):1139-47. PubMed ID: 15486837
    [Abstract] [Full Text] [Related]

  • 9. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D, Djossou F, Schilthuis HJ, Høgh B, Dutoit E, Malvy D, Roskell NS, Hedgley C, De Boever EH, Miller GB, International Malarone Study Team.
    Clin Infect Dis; 2004 Jun 15; 38(12):1716-23. PubMed ID: 15227617
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Atovaquone/proguanil. Prophylaxis and treatment of malaria].
    Lundgren JD, Dragsted UB.
    Ugeskr Laeger; 2000 Jul 31; 162(31):4177-81. PubMed ID: 10962933
    [Abstract] [Full Text] [Related]

  • 13. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD, Maguire JD, Barcus MJ, Ling J, Bangs MJ, Gramzinski R, Basri H, Sismadi P, Miller GB, Chulay JD, Fryauff DJ, Hoffman SL, Baird JK.
    Clin Infect Dis; 2002 Nov 01; 35(9):e92-5. PubMed ID: 12384852
    [Abstract] [Full Text] [Related]

  • 14. Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in Zambia.
    Mulenga M, Sukwa TY, Canfield CJ, Hutchinson DB.
    Clin Ther; 1999 May 01; 21(5):841-52. PubMed ID: 10397379
    [Abstract] [Full Text] [Related]

  • 15. Atovaquone-proguanil for prophylaxis and treatment of malaria.
    Marra F, Salzman JR, Ensom MH.
    Ann Pharmacother; 2003 Sep 01; 37(9):1266-75. PubMed ID: 12921511
    [Abstract] [Full Text] [Related]

  • 16. Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national antimalarial drug recommendations.
    Mayxay M, Newton PN, Khanthavong M, Tiengkham P, Phetsouvanh R, Phompida S, Brockman A, White NJ.
    Clin Infect Dis; 2003 Oct 15; 37(8):1021-8. PubMed ID: 14523765
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of atovaquone-proguanil for treatment of acute multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Krudsood S, Patel SN, Tangpukdee N, Thanachartwet W, Leowattana W, Pornpininworakij K, Boggild AK, Looareesuwan S, Kain KC.
    Am J Trop Med Hyg; 2007 Apr 15; 76(4):655-8. PubMed ID: 17426165
    [Abstract] [Full Text] [Related]

  • 18. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL, Naval Medical Research Unit 2 Clinical Trial Team.
    Clin Infect Dis; 2002 Oct 01; 35(7):825-33. PubMed ID: 12228819
    [Abstract] [Full Text] [Related]

  • 19. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB.
    Am J Trop Med Hyg; 1999 Apr 01; 60(4):533-41. PubMed ID: 10348225
    [Abstract] [Full Text] [Related]

  • 20. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa.
    Kuhn S, Gill MJ, Kain KC.
    Am J Trop Med Hyg; 2005 Apr 01; 72(4):407-9. PubMed ID: 15827276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.